Fibrinolysin
Generic Name: fibrinolysin
Manufactured by PARKE DAVIS. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: CHLORAMPHENICOL (10MG/GM); DESOXYRIBONUCLEASE (666 UNITS/GM); FIBRINOLYSIN (1 UNITS/GM). Application: BLA050294.
Overview
Manufactured by PARKE DAVIS. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: CHLORAMPHENICOL (10MG/GM); DESOXYRIBONUCLEASE (666 UNITS/GM); FIBRINOLYSIN (1 UNITS/GM). Application: BLA050294.
Dosage
Available as ointment for topical use.
Related Medications
Ferr Phos, Kali Mur, Kali Sulf, Nat Mur, Nat Sulf
ferr phos, kali mur, kali sulf, nat mur, nat sulf
Uses Temporarily relieves occasional elevated body temperature and the early stages of body stress, including heat, discomfort, redness, and swelling.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Desoxycorticosterone Acetate
desoxycorticosterone acetate
Manufactured by NOVARTIS. Dosage form: PELLET. Route: IMPLANTATION. Active ingredients: DESOXYCORTICOSTERONE ACETATE (125MG). Application: NDA005151.
Azilsartan Kamedoxomil
azilsartan kamedoxomil
11 DESCRIPTION Edarbi (azilsartan medoxomil), a prodrug, is hydrolyzed to azilsartan in the gastrointestinal tract during absorption. Azilsartan is an angiotensin II receptor blocker. The drug substance used in the drug product formulation is the potassium salt of azilsartan medoxomil, also known by the US accepted name of azilsartan kamedoxomil and is chemically described as (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1 H.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.